NCT05171569

Brief Summary

The Post discharge after surgery Virtual Care with Remote Automated Monitoring technology (PVC-RAM)-3 Trial is a multicentre, parallel group, superiority, randomized controlled trial to determine the effect of virtual care with remote automated monitoring (RAM) technology compared to standard care on length of index hospital stay and use of acute hospital care (composite of hospital readmission and emergency department visit) after randomization, in adults who have undergone elective non cardiac surgery. Secondary outcomes at 30 days after randomization include: 1) hospital re-admission; 2) emergency department visit; 3) medication error detection;4) medication error correction; 5) surgical site infection; and 6) days in hospital. Additional secondary outcomes are pain of any severity, and moderate-to-severe pain assessed at 15 and 30 days after randomization. The investigators will also assess optimal management of long-term health by evaluating among patients with atherosclerotic disease and current smokers whether patients are taking classes of efficacious medications at 30 days.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,500

participants targeted

Target at P75+ for not_applicable surgery

Timeline
Completed

Started Dec 2021

Typical duration for not_applicable surgery

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 10, 2021

Completed
18 days until next milestone

Study Start

First participant enrolled

December 28, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 29, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

March 27, 2025

Status Verified

March 1, 2025

Enrollment Period

2.9 years

First QC Date

December 10, 2021

Last Update Submit

March 24, 2025

Conditions

Keywords

Virtual care

Outcome Measures

Primary Outcomes (2)

  • Index hospital length of stay

    Length of stay from randomization until discharge from the index hospitalization (measured in days and hours)

    30 Days post randomization

  • Acute hospital care (composite of hospital readmission and emergency department visit)

    Acute-hospital care is a composite outcome of hospital re-admission and emergency department visit, which includes urgent-care centre visit.

    30 Days post randomization

Secondary Outcomes (8)

  • Hospital readmission

    30 days post randomization

  • Emergency department visit (includes urgent care centre visit)

    30 days post randomization

  • Medication error detection

    30 days post randomization

  • Medication error correction

    30 days post randomization

  • Surgical site infection

    30 days post randomization

  • +3 more secondary outcomes

Other Outcomes (6)

  • Infection

    30 days post randomization

  • Re-operation

    30 days post randomization

  • Composite of myocardial infarction, acute heart failure, and arrhythmia that results in acute hospital care

    30 days post randomization

  • +3 more other outcomes

Study Arms (2)

Virtual Care with Remote Automated Monitoring

EXPERIMENTAL

Patients randomized to the PVC-RAM-3 intervention will take biophysical measurements with the RAM technology, complete a daily recovery survey, complete video visits with a virtual care clinical team, and take wound photos during the 14 days after discharge. If the patient's RAM measurements exceed predetermined thresholds, the patient reports specific symptoms (e.g., shortness of breath), a drug error is identified, or the virtual nurse has concerns about the patient's health that they cannot resolve, the virtual nurse will escalate care to a pre-assigned and available physician.

Device: Virtual care with remote automated monitoring (RAM)

Standard Care

NO INTERVENTION

Standard post surgical care per treating institution.

Interventions

Use of Cloud Diagnostics connected health kit for at home monitoring with virtual clinical from nursing and perioperative physician team.

Virtual Care with Remote Automated Monitoring

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • are ≥18 years of age;
  • are undergoing inpatient elective noncardiac surgery with an expected length of hospital stay ≤3 days after surgery; and
  • provide informed consent to participate.

You may not qualify if:

  • are unable to communicate with research staff, complete study surveys, or undertake an interview using a tablet computer due to a language barrier or a cognitive, visual, or hearing impairment; or
  • reside in an area without cellular network coverage.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hamilton General Hospital

Hamilton, Ontario, Canada

Location

Juravinski Hospital

Hamilton, Ontario, Canada

Location

Related Publications (1)

  • Ofori S, McGillion MH, Borges FK, Ouellette C, Patel A, Conen D, Marcucci M, Wang MK, Park LJ, Bell C, Lounsbury J, Nagatani K, Tandon V, Wilkieson TJ, Wyne A, Harvey V, Harrison S, Nenshi R, Bogach J, Harlock J, Cadeddu M, Forbes S, Haider S, Mirza RD, Narang S, Reade CJ, Tushinski DM, Raut A, Raza S, Scott T, Adili A, Petch J, Devereaux PJ. Impact of Virtual Care With Remote Automated Monitoring on the Rate of Acute Hospital Care Post Discharge and Index Length of Hospital Stay: Protocol for the Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology 3 (PVC-RAM-3) Trial. JMIR Res Protoc. 2025 Jun 2;14:e72672. doi: 10.2196/72672.

Study Officials

  • Michael McGillion, PhD

    McMaster University, Population Health Research Institute

    PRINCIPAL INVESTIGATOR
  • PJ Devereaux, M.D, PhD

    McMaster University, Population Health Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2021

First Posted

December 29, 2021

Study Start

December 28, 2021

Primary Completion

November 30, 2024

Study Completion

May 31, 2025

Last Updated

March 27, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations